Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Vapotherm stock | 27.32

Own Vapotherm stock in just a few minutes.


Fact checked

Vapotherm, Inc is a medical devices business based in the US. Vapotherm shares (VAPO) are listed on the NYSE and all prices are listed in US Dollars. Vapotherm employs 279 staff and has a trailing 12-month revenue of around USD$97.8 million.

How to buy shares in Vapotherm

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Vapotherm. Find the stock by name or ticker symbol: VAPO. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Vapotherm reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$27.32, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Vapotherm, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Vapotherm. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Vapotherm's share price?

Since the stock market crash in March caused by coronavirus, Vapotherm's share price has had significant positive movement.

Its last market close was USD$27.32, which is 65.85% up on its pre-crash value of USD$9.33 and 298.25% up on the lowest point reached during the March crash when the shares fell as low as USD$6.86.

If you had bought USD$1,000 worth of Vapotherm shares at the start of February 2020, those shares would have been worth USD$1,421.93 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$2,790.74.

Vapotherm share price

Use our graph to track the performance of VAPO stocks over time.

Vapotherm shares at a glance

Information last updated 2020-11-23.
Latest market close USD$27.32
52-week range USD$6.86 - USD$54.42
50-day moving average USD$28.6686
200-day moving average USD$32.6989
Wall St. target price USD$42.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-4.384

Buy Vapotherm shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Stocks, Mutual funds, ETFs, Forex
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Vapotherm stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Vapotherm price performance over time

Historical closes compared with the close of $27.32 from 2020-11-16

1 week (2020-11-16) N/A
1 month (2020-10-27) -9.57%
3 months (2020-08-23) N/A
6 months (2020-05-23) N/A
1 year (2019-11-23) N/A
2 years (2018-11-23) N/A
3 years (2017-11-23) N/A
5 years (2015-11-23) N/A

Vapotherm financials

Revenue TTM USD$97.8 million
Gross profit TTM USD$21.3 million
Return on assets TTM -16.84%
Return on equity TTM -48.29%
Profit margin -47.8%
Book value $5.017
Market capitalisation USD$668.7 million

TTM: trailing 12 months

Shorting Vapotherm shares

There are currently 2.4 million Vapotherm shares held short by investors – that's known as Vapotherm's "short interest". This figure is 4.1% up from 2.3 million last month.

There are a few different ways that this level of interest in shorting Vapotherm shares can be evaluated.

Vapotherm's "short interest ratio" (SIR)

Vapotherm's "short interest ratio" (SIR) is the quantity of Vapotherm shares currently shorted divided by the average quantity of Vapotherm shares traded daily (recently around 501362.1399177). Vapotherm's SIR currently stands at 4.86. In other words for every 100,000 Vapotherm shares traded daily on the market, roughly 4860 shares are currently held short.

However Vapotherm's short interest can also be evaluated against the total number of Vapotherm shares, or, against the total number of tradable Vapotherm shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Vapotherm's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Vapotherm shares in existence, roughly 100 shares are currently held short) or 0.1234% of the tradable shares (for every 100,000 tradable Vapotherm shares, roughly 123 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Vapotherm.

Find out more about how you can short Vapotherm stock.

Vapotherm share dividends

We're not expecting Vapotherm to pay a dividend over the next 12 months.

Have Vapotherm's shares ever split?

Vapotherm's shares were split on a 1:50 basis on 10 September 2014. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Vapotherm shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for Vapotherm shares which in turn could have impacted Vapotherm's share price.

Vapotherm share price volatility

Over the last 12 months, Vapotherm's shares have ranged in value from as little as $6.86 up to $54.42. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Vapotherm's is -1.4272. This would suggest that Vapotherm's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Vapotherm has bucked the trend.

Vapotherm overview

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; tracheostomy adaptors; and ProSoft cannula to provide gentle contact with the skin. In addition, Vapotherm, Inc. offers aerosol disposable patient circuit that is designed to streamline the provision of intermittent and continuous aerosol nebulization by limiting condensate management; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is based in Exeter, New Hampshire.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site